Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
106M
-
Number of holders
-
175
-
Total 13F shares, excl. options
-
39.4M
-
Shares change
-
-3.16M
-
Total reported value, excl. options
-
$1.08B
-
Value change
-
-$176M
-
Put/Call ratio
-
0.71
-
Number of buys
-
97
-
Number of sells
-
-100
-
Price
-
$27.43
Significant Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q4 2016
277 filings reported holding SRPT - Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q4 2016.
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) has 175 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39.4M shares
of 106M outstanding shares and own 37.27% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (3.92M shares), PERCEPTIVE ADVISORS LLC (2.77M shares), STATE STREET CORP (2.64M shares), BlackRock Fund Advisors (2.26M shares), CARLSON CAPITAL L P (2.2M shares), SABBY MANAGEMENT, LLC (2.01M shares), Tourbillon Capital Partners, L.P. (1.63M shares), Point72 Asset Management, L.P. (1.37M shares), BlackRock Institutional Trust Company, N.A. (1.31M shares), and FMR LLC (1.2M shares).
This table shows the top 175 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.